COVID VACCINE MAKERS PREPARE TO LAUNCH NEW-GENERATION JABS AMID VARIANT CONCERNS
Why in the news?
- Hyderabad-based Biological E initiates clinical trials for next-generation Covid vaccine targeting the XBB1.5 variant.
- Aimed at combating evolving strains of SARS-CoV-2, particularly amid rising cases worldwide.
About India SARS-CoV-2 Genomics Consortium (INSACOG):
- India SARS-CoV-2 Genomics Consortium (INSACOG) initiated by the Health Ministry, DBT, CSIR, and ICMR.
- Consists of 54 labs monitoring genomic variations in SARS-CoV-2 through sentinel sequencing.
- Established to expand whole genome sequencing, aiding understanding of virus spread, evolution, and informing public health response.
- Samples analyzed to observe genetic code changes and virus mutations, crucial for vaccine development and response strategies.
source:scribd
About the Covid Omicron XBB1.5 variant:
|